NDC 0310-9420 – Wainua

Eplontersen 45 mg/.8mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0310-9420

Product details

Brand name
Wainua
Generic name
Eplontersen
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA217388
Marketed since
April 30, 2026
Listing expires
December 31, 2027
Pharmacologic class
Antisense Oligonucleotide; Transthyretin-directed RNA Interaction

Active ingredients

Uses, dosage, side effects and warnings for Wainua →

Package NDC codes (1)

Package NDCDescriptionSince
0310-9420-011 SYRINGE, GLASS in 1 CARTON (0310-9420-01) / .8 mL in 1 SYRINGE, GLASSApr 30, 2026

Other Wainua products